Registered entities
Aslan Pharmaceuticals Pte Ltd
Reg. No. 201007695NSingapore
Innovation
58 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 1,132 times.
| Year | Filings |
|---|---|
| 2015 | 5 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 8 |
| 2019 | 12 |
| 2020 | 7 |
| 2021 | 4 |
| 2022 | 11 |
| 2023 | 18 |
| 2024 | 9 |
| 2025 | 9 |
| 2026 | 1 |
Investor mix
17 investors on record; lead investors include MVP Capital Partners, Milestone Capital, Cenova, Accuron Technologies; 5 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 29% |
| Private equity | 6 | 35% |
| Bank & private debt | 3 | 18% |
| Other / undisclosed | 3 | 18% |